Background And Objective: Long-term effectiveness of action plans in patients with chronic obstructive pulmonary disease (COPD) is minimally investigated. We have evaluated the (cost-)effectiveness of a self-management programme with or without self-treatment of exacerbations after 2 years follow-up.

Methods: Self-management with or without self-treatment of exacerbations was randomly assigned to patients. All patients participated in four self-management meetings. Patients in the self-treatment group (STG) also learned to use an action plan to start a course of prednisolone and/or antibiotics in case of worsening of symptoms. Primary outcome was the duration and severity of exacerbations.

Results: Data of 70 COPD patients in the STG and 72 patients in the control group (CG) were analysed. Over 2 years, the median number of exacerbation days was significantly lower in the STG (50, IQR: 32-115) compared with the CG (82, IQR: 22-186) (P = 0.047), as was the mean symptom score of an exacerbation (STG: 43.4, IQR 27.2-68.6 vs CG: 55.9, IQR: 31.2-96.8) (P = 0.029). Also, patients in the STG visited the respiratory physician and emergency department less frequently than patients in the CG with incidence rate ratios of 1.52 (95% CI: 1.28-1.79) and 2.27 (95% CI: 1.11-4.62), respectively. Direct medical costs per patient over 2 years were €1078 lower in the STG.

Conclusion: Self-treatment of exacerbations is beneficial in COPD patients without significant comorbidities because it reduces exacerbation duration, exacerbation severity and health-care utilization leading to considerable cost savings.

Download full-text PDF

Source
http://dx.doi.org/10.1111/resp.12697DOI Listing

Publication Analysis

Top Keywords

self-treatment exacerbations
16
patients
10
copd patients
8
patients stg
8
stg
5
cost-effectiveness self-treatment
4
exacerbations
4
exacerbations patients
4
copd
4
patients copd
4

Similar Publications

Introduction: Patients' adherence is essential for COPD self-management, as beneficial effects can only be expected in adherent patients. We explored associations between patients' adherence to COPD exacerbation action plans and health outcomes.

Materials And Methods: Pooled COPD self-treatment intervention group data from two RCTs were analysed, only including patients who had ≥1 COPD exacerbation or started ≥1 course of oral corticosteroids over one-year follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • Older adults (≥65 years) are the biggest users of over-the-counter medications but are at high risk for misuse, leading to potential harmful effects.
  • This study recruited 144 older adults from 10 community pharmacies to investigate how they select and plan to use OTC medications when faced with hypothetical symptoms.
  • Results showed that 79% of participants exhibited misuse of OTCs, particularly in drug-drug and drug-label categories, with misuse increasing when participants sought to treat worsening symptoms, underlining the urgent need for enhanced OTC safety measures.
View Article and Find Full Text PDF

We aimed to illuminate the challenges of treating anal diseases among gay, bisexual and other men who have sex with men (GBMSM) in a homophobic climate amid resource constraints. Building on a long-term Kenyan-Canadian collaboration, an anal healthcare intervention study, known as the WEMAH Project, was initiated in January 2022. The initial collaborative work strengthened existing anal health services provided at a community-based clinic serving GBMSM in Nairobi.

View Article and Find Full Text PDF
Article Synopsis
  • Hereditary angioedema (HAE) is a rare condition characterized by a deficiency in C1 esterase inhibitor, leading to recurrent episodes of swelling, which can worsen during pregnancy due to hormonal changes and stress.
  • A case study describes a pregnant patient with HAE who successfully had a vaginal delivery with neuraxial anesthesia, highlighting the importance of C1-inhibitor prophylaxis and postpartum monitoring.
  • Effective management of HAE during pregnancy and delivery requires timely consultations, access to emergency airway supplies, and a coordinated approach among healthcare providers to ensure the safety of both the mother and baby.
View Article and Find Full Text PDF

Travel Medicine.

Ann Intern Med

September 2023

Harvard Medical School, Boston, Massachusetts (E.T.R., R.C.L.).

International travel can cause new illness or exacerbate existing conditions. Because primary care providers are frequent sources of health advice to travelers, they should be familiar with destination-specific disease risks, be knowledgeable about travel and routine vaccines, be prepared to prescribe chemoprophylaxis and self-treatment regimens, and be aware of travel medicine resources. Primary care providers should recognize travelers who would benefit from referral to a specialized travel clinic for evaluation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!